尿路上皮がん診断の世界市場（～2026年）

• 英文タイトル：Global Urothelial Carcinoma Diagnostics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04955
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療機器・消耗品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は尿路上皮がん診断のグローバル市場について調査・分析したレポートです。種類別（使用機器、試薬、キット）市場規模、用途別（委託研究機関、学術機関、病院、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別尿路上皮がん診断の競争状況、市場シェア
・世界の尿路上皮がん診断市場：種類別市場規模 2015年-2020年（使用機器、試薬、キット）
・世界の尿路上皮がん診断市場：種類別市場規模予測 2021年-2026年（使用機器、試薬、キット）
・世界の尿路上皮がん診断市場：用途別市場規模 2015年-2020年（委託研究機関、学術機関、病院、診断センター）
・世界の尿路上皮がん診断市場：用途別市場規模予測 2021年-2026年（委託研究機関、学術機関、病院、診断センター）
・北米の尿路上皮がん診断市場分析：米国、カナダ
・ヨーロッパの尿路上皮がん診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの尿路上皮がん診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の尿路上皮がん診断市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの尿路上皮がん診断市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Roche Holding、Illumina、IDL Biotech、Agilent Technologies、Olympus、Philips Healthcare、GE Healthcare
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis.
The increasing trends of cigarette smoking is increasing the chances of urothelial carcinoma manifold.

Market Analysis and Insights: Global Urothelial Carcinoma Diagnostics Market
The global Urothelial Carcinoma Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Urothelial Carcinoma Diagnostics Scope and Market Size
Urothelial Carcinoma Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Urothelial Carcinoma Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche Holding
Illumina
IDL Biotech
Agilent Technologies
Olympus
Philips Healthcare
GE Healthcare
…

Market segment by Type, the product can be split into
Instruments Used
Reagents and kits
Market segment by Application, split into
Contract Research Organizations
Academic Institutions
Hospitals
Diagnostic Centres

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Urothelial Carcinoma Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Urothelial Carcinoma Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments Used
1.4.3 Reagents and kits
1.5 Market by Application
1.5.1 Global Urothelial Carcinoma Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Contract Research Organizations
1.5.3 Academic Institutions
1.5.4 Hospitals
1.5.5 Diagnostic Centres
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Urothelial Carcinoma Diagnostics Market Perspective (2015-2026)
2.2 Global Urothelial Carcinoma Diagnostics Growth Trends by Regions
2.2.1 Urothelial Carcinoma Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Urothelial Carcinoma Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Urothelial Carcinoma Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Urothelial Carcinoma Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Urothelial Carcinoma Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Urothelial Carcinoma Diagnostics Players by Market Size
3.1.1 Global Top Urothelial Carcinoma Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Urothelial Carcinoma Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Urothelial Carcinoma Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Urothelial Carcinoma Diagnostics Market Concentration Ratio
3.2.1 Global Urothelial Carcinoma Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Urothelial Carcinoma Diagnostics Revenue in 2019
3.3 Urothelial Carcinoma Diagnostics Key Players Head office and Area Served
3.4 Key Players Urothelial Carcinoma Diagnostics Product Solution and Service
3.5 Date of Enter into Urothelial Carcinoma Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Urothelial Carcinoma Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Urothelial Carcinoma Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)
5.2 Global Urothelial Carcinoma Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Urothelial Carcinoma Diagnostics Market Size (2015-2020)
6.2 Urothelial Carcinoma Diagnostics Key Players in North America (2019-2020)
6.3 North America Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
6.4 North America Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Urothelial Carcinoma Diagnostics Market Size (2015-2020)
7.2 Urothelial Carcinoma Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
7.4 Europe Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

8 China
8.1 China Urothelial Carcinoma Diagnostics Market Size (2015-2020)
8.2 Urothelial Carcinoma Diagnostics Key Players in China (2019-2020)
8.3 China Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
8.4 China Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Urothelial Carcinoma Diagnostics Market Size (2015-2020)
9.2 Urothelial Carcinoma Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
9.4 Japan Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Urothelial Carcinoma Diagnostics Market Size (2015-2020)
10.2 Urothelial Carcinoma Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

11 India
11.1 India Urothelial Carcinoma Diagnostics Market Size (2015-2020)
11.2 Urothelial Carcinoma Diagnostics Key Players in India (2019-2020)
11.3 India Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
11.4 India Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Urothelial Carcinoma Diagnostics Market Size (2015-2020)
12.2 Urothelial Carcinoma Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Roche Holding
13.1.1 Roche Holding Company Details
13.1.2 Roche Holding Business Overview
13.1.3 Roche Holding Urothelial Carcinoma Diagnostics Introduction
13.1.4 Roche Holding Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020))
13.1.5 Roche Holding Recent Development
13.2 Illumina
13.2.1 Illumina Company Details
13.2.2 Illumina Business Overview
13.2.3 Illumina Urothelial Carcinoma Diagnostics Introduction
13.2.4 Illumina Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020)
13.2.5 Illumina Recent Development
13.3 IDL Biotech
13.3.1 IDL Biotech Company Details
13.3.2 IDL Biotech Business Overview
13.3.3 IDL Biotech Urothelial Carcinoma Diagnostics Introduction
13.3.4 IDL Biotech Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020)
13.3.5 IDL Biotech Recent Development
13.4 Agilent Technologies
13.4.1 Agilent Technologies Company Details
13.4.2 Agilent Technologies Business Overview
13.4.3 Agilent Technologies Urothelial Carcinoma Diagnostics Introduction
13.4.4 Agilent Technologies Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020)
13.4.5 Agilent Technologies Recent Development
13.5 Olympus
13.5.1 Olympus Company Details
13.5.2 Olympus Business Overview
13.5.3 Olympus Urothelial Carcinoma Diagnostics Introduction
13.5.4 Olympus Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020)
13.5.5 Olympus Recent Development
13.6 Philips Healthcare
13.6.1 Philips Healthcare Company Details
13.6.2 Philips Healthcare Business Overview
13.6.3 Philips Healthcare Urothelial Carcinoma Diagnostics Introduction
13.6.4 Philips Healthcare Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020)
13.6.5 Philips Healthcare Recent Development
13.7 GE Healthcare
13.7.1 GE Healthcare Company Details
13.7.2 GE Healthcare Business Overview
13.7.3 GE Healthcare Urothelial Carcinoma Diagnostics Introduction
13.7.4 GE Healthcare Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020)
13.7.5 GE Healthcare Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Urothelial Carcinoma Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Urothelial Carcinoma Diagnostics Revenue
Table 3. Ranking of Global Top Urothelial Carcinoma Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Urothelial Carcinoma Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instruments Used
Table 6. Key Players of Reagents and kits
Table 7. Global Urothelial Carcinoma Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Urothelial Carcinoma Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Urothelial Carcinoma Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Urothelial Carcinoma Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Urothelial Carcinoma Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Urothelial Carcinoma Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Urothelial Carcinoma Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Urothelial Carcinoma Diagnostics Players
Table 18. Global Urothelial Carcinoma Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Urothelial Carcinoma Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Urothelial Carcinoma Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urothelial Carcinoma Diagnostics as of 2019)
Table 21. Global Urothelial Carcinoma Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Urothelial Carcinoma Diagnostics Product Solution and Service
Table 24. Date of Enter into Urothelial Carcinoma Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Urothelial Carcinoma Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Urothelial Carcinoma Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Urothelial Carcinoma Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Urothelial Carcinoma Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 34. North America Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 36. North America Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 40. Europe Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 46. China Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 48. China Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 52. Japan Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 64. India Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 66. India Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Urothelial Carcinoma Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Urothelial Carcinoma Diagnostics Market Share (2019-2020)
Table 70. Central & South America Urothelial Carcinoma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Urothelial Carcinoma Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Urothelial Carcinoma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Urothelial Carcinoma Diagnostics Market Share by Application (2015-2020)
Table 74. Roche Holding Company Details
Table 75. Roche Holding Business Overview
Table 76. Roche Holding Product
Table 77. Roche Holding Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 78. Roche Holding Recent Development
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Product
Table 82. Illumina Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 83. Illumina Recent Development
Table 84. IDL Biotech Company Details
Table 85. IDL Biotech Business Overview
Table 86. IDL Biotech Product
Table 87. IDL Biotech Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 88. IDL Biotech Recent Development
Table 89. Agilent Technologies Company Details
Table 90. Agilent Technologies Business Overview
Table 91. Agilent Technologies Product
Table 92. Agilent Technologies Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 93. Agilent Technologies Recent Development
Table 94. Olympus Company Details
Table 95. Olympus Business Overview
Table 96. Olympus Product
Table 97. Olympus Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 98. Olympus Recent Development
Table 99. Philips Healthcare Company Details
Table 100. Philips Healthcare Business Overview
Table 101. Philips Healthcare Product
Table 102. Philips Healthcare Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 103. Philips Healthcare Recent Development
Table 104. GE Healthcare Company Details
Table 105. GE Healthcare Business Overview
Table 106. GE Healthcare Product
Table 107. GE Healthcare Revenue in Urothelial Carcinoma Diagnostics Business (2015-2020) (Million US$)
Table 108. GE Healthcare Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urothelial Carcinoma Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Instruments Used Features
Figure 3. Reagents and kits Features
Figure 4. Global Urothelial Carcinoma Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Contract Research Organizations Case Studies
Figure 6. Academic Institutions Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centres Case Studies
Figure 9. Urothelial Carcinoma Diagnostics Report Years Considered
Figure 10. Global Urothelial Carcinoma Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Urothelial Carcinoma Diagnostics Market Share by Regions: 2020 VS 2026
Figure 12. Global Urothelial Carcinoma Diagnostics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Urothelial Carcinoma Diagnostics Market Share by Players in 2019
Figure 15. Global Top Urothelial Carcinoma Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urothelial Carcinoma Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Urothelial Carcinoma Diagnostics Revenue in 2019
Figure 17. North America Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Urothelial Carcinoma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

尿路上皮がん治療の世界市場（～2026年）

Global Urothelial Carcinoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04956 2020年11月20日 93Pages
当調査資料は尿路上皮がん治療のグローバル市場について調査・分析したレポートです。種類別（免疫療法、放射線療法、化学療法）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

結腸・直腸がんの世界市場（～2026年）

Global Colon & Rectal Carcinoma Market Size, Status and Forecast 2020-2026
MRC2-11QY11432 2020年11月25日 94Pages
当調査資料は結腸・直腸がんのグローバル市場について調査・分析したレポートです。種類別（大腸がん治療、直腸がん治療）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾...

副腎皮質がん治療の世界市場（～2026年）

Global Adrenocortical Carcinoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13578 2020年11月30日 92Pages
当調査資料は副腎皮質がん治療のグローバル市場について調査・分析したレポートです。種類別（限局性副腎皮質がん、転移性副腎皮質がん）市場規模、用途別（病院、外来手術センター、診療所、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

基底細胞がん（BCC）治療薬の世界市場（～2026年）

Global Basal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11023 2020年11月25日 91Pages
当調査資料は基底細胞がん（BCC）治療薬のグローバル市場について調査・分析したレポートです。種類別（手術、放射線療法、光線力学療法、薬物）市場規模、用途別（小売薬局、病院薬局、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

神経内分泌がんの世界市場（～2026年）

Global Neuroendocrine Carcinoma Market Size, Status and Forecast 2020-2026
MRC2-11QY03951 2020年11月20日 96Pages
当調査資料は神経内分泌がんのグローバル市場について調査・分析したレポートです。種類別（化学療法、ソマトスタチン類似体、標的療法）市場規模、用途別（病院、診療所、腫瘍学センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

頭頸部がん診断の世界市場（～2026年）

Global Head and Neck Cancer Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY12103 2020年11月25日 91Pages
当調査資料は頭頸部がん診断のグローバル市場について調査・分析したレポートです。種類別（画像診断、内視鏡検査、生検検査、血液検査、歯科診断、その他）市場規模、用途別（病院、専門クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

獣医分子診断の世界市場（～2026年）

Global Veterinary Molecular Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY05016 2020年11月20日 99Pages
当調査資料は獣医分子診断のグローバル市場について調査・分析したレポートです。種類別（機器、試薬、サービス、ソフトウェア）市場規模、用途別（獣医病院、臨床検査室、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

高度腎細胞癌治療薬の世界市場（～2026年）

Global Advanced Renal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13590 2020年11月30日 125Pages
当調査資料は高度腎細胞癌治療薬のグローバル市場について調査・分析したレポートです。種類別（放射線療法、化学療法、ホルモン療法、治験療法）市場規模、用途別（病院、がん研究所、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

迅速診断の世界市場（～2026年）

Global Rapid Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY04452 2020年11月20日 130Pages
当調査資料は迅速診断のグローバル市場について調査・分析したレポートです。種類別（店頭（OTC）迅速診断テスト、プロフェッショナル迅速診断テスト）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

医療関連感染（HAI）診断の世界市場（～2026年）

Global Hospital Acquired Infections (HAI) Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY12230 2020年11月25日 93Pages
当調査資料は医療関連感染（HAI）診断のグローバル市場について調査・分析したレポートです。種類別（分子診断検査、その他体外診断検査）市場規模、用途別（菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

尿路上皮がん治療の世界市場（～2026年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…
基底細胞がん（BCC）治療薬の世界市場（～2026年） Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…
結腸・直腸がんの世界市場（～2026年） Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Colon & Rectal Carcinoma Scope and Market Size Colon & Rectal Car…
神経内分泌がんの世界市場（～2026年） Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …